{
  "question_stem": {
    "en": "A 44-year-old man comes to the office due to paresthesia and pain in his feet. The patient began experiencing tingling and numbness in his toes several months ago, which gradually progressed to the rest of both feet. He has also had burning pain on the soles, which frequently disrupts his sleep at night. The patient has a 6-year history of HIV infection. He was not adherent to treatment initially but now takes antiretroviral therapy regularly. His most recent CD4 cell count was 550/mm³. Vital signs are within normal limits. Foot examination shows decreased pain and touch sensation and loss of ankle reflexes bilaterally. There are no other focal neurologic deficits. Medication review shows no neurotoxic drugs and laboratory studies are within normal limits. Treatment with duloxetine is planned. This medication is most likely to improve this patient's symptoms via which of the following mechanisms?",
    "zh": "一名44岁男性因足部感觉异常和疼痛来诊。患者几个月前开始出现足趾麻刺和麻木，并逐渐蔓延到双足其他部位。他还出现足底烧灼痛，经常在夜间干扰睡眠。患者有6年HIV感染史。最初未坚持治疗，但现在定期服用抗逆转录病毒治疗。他最近的CD4细胞计数为550/mm³。生命体征在正常范围内。足部检查显示双侧痛觉和触觉减退，踝反射消失。没有其他局灶性神经功能缺损。药物回顾显示无神经毒性药物，实验室检查在正常范围内。计划用度洛西汀治疗。该药物最有可能通过以下哪种机制改善患者的症状？"
  },
  "question": {
    "en": "This medication is most likely to improve this patient's symptoms via which of the following mechanisms?",
    "zh": "该药物最有可能通过以下哪种机制改善患者的症状？"
  },
  "options": {
    "A": {
      "en": "Decreased sensitization of sensory afferent neurons",
      "zh": "感觉传入神经元敏感性降低"
    },
    "B": {
      "en": "Decreased substance P-induced activation of dorsal horn neurons",
      "zh": "P物质诱导的背角神经元活化减少"
    },
    "C": {
      "en": "Frequency-dependent blockade of neuronal conductance",
      "zh": "神经元传导的频率依赖性阻滞"
    },
    "D": {
      "en": "Inhibition of GABA release by periaqueductal gray neurons",
      "zh": "导水管周围灰质神经元对GABA释放的抑制"
    },
    "E": {
      "en": "Norepinephrine-mediated descending pain pathway modulation",
      "zh": "去甲肾上腺素介导的下行疼痛通路调节"
    }
  },
  "correct_answer": "E",
  "explanation": {
    "en": "The patient has symptoms consistent with HIV-associated peripheral neuropathy. Duloxetine is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is a first-line treatment for painful diabetic neuropathy and other neuropathic pain conditions. SNRIs work by increasing the levels of serotonin and norepinephrine in the synaptic cleft. Norepinephrine, in particular, plays a crucial role in the descending pain inhibitory pathways. By enhancing norepinephrine signaling in these pathways, SNRIs modulate the transmission of pain signals in the central nervous system, leading to decreased perception of pain.\n\n(Choice A) Decreased sensitization of sensory afferent neurons is a mechanism of action for nonsteroidal anti-inflammatory drugs (NSAIDs), which are generally not effective for neuropathic pain. \n(Choice B) Decreased substance P-induced activation of dorsal horn neurons is a mechanism associated with opioid analgesia. While opioids can be used for neuropathic pain, they are not typically first-line due to risks of dependence and abuse.\n(Choice C) Frequency-dependent blockade of neuronal conductance is the mechanism of action for certain anticonvulsants, such as carbamazepine, which are used for conditions like trigeminal neuralgia.\n(Choice D) Inhibition of GABA release by periaqueductal gray neurons is a mechanism related to descending pain modulation, but it is not the primary mechanism of action for SNRIs. Opioids can also influence GABAergic transmission in pain pathways.\n\nKey Pearls:\n- Duloxetine is an SNRI used for neuropathic pain.\n- SNRIs enhance descending pain inhibition via norepinephrine.\n- Differentiate mechanisms of action for different classes of analgesics.",
    "zh": "患者的症状与HIV相关性周围神经病变一致。度洛西汀是一种5-羟色胺-去甲肾上腺素再摄取抑制剂（SNRI），是治疗糖尿病性神经病变疼痛和其他神经病理性疼痛的首选药物。SNRIs通过增加突触间隙中5-羟色胺和去甲肾上腺素的水平发挥作用。特别是去甲肾上腺素，在下行疼痛抑制通路中起关键作用。通过增强这些通路中的去甲肾上腺素信号传导，SNRIs调节中枢神经系统中疼痛信号的传递，从而降低疼痛感知。\n\n（选项A）感觉传入神经元敏感性降低是非甾体类抗炎药（NSAIDs）的作用机制，NSAIDs通常对神经病理性疼痛无效。\n（选项B）P物质诱导的背角神经元活化减少与阿片类镇痛有关。虽然阿片类药物可用于神经病理性疼痛，但由于存在依赖性和滥用风险，通常不是一线用药。\n（选项C）神经元传导的频率依赖性阻滞是某些抗惊厥药（如卡马西平）的作用机制，这些药物用于治疗三叉神经痛等疾病。\n（选项D）导水管周围灰质神经元对GABA释放的抑制与下行疼痛调节有关，但它不是SNRIs的主要作用机制。阿片类药物也会影响疼痛通路中的GABA能传递。\n\n关键要点：\n- 度洛西汀是一种用于神经病理性疼痛的SNRI。\n- SNRIs通过去甲肾上腺素增强下行疼痛抑制。\n- 区分不同类别镇痛药的作用机制。"
  },
  "summary": {
    "en": "This question tests the understanding of the mechanism of action of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), in the management of neuropathic pain, specifically in the context of HIV-associated peripheral neuropathy.\n\nThe approach to solving this question involves identifying the drug class of duloxetine (SNRI) and recalling its primary mechanism of action, which involves modulating descending pain pathways through the enhancement of norepinephrine signaling. This contrasts with the mechanisms of other analgesic classes.",
    "zh": "此题考察对度洛西汀（一种5-羟色胺-去甲肾上腺素再摄取抑制剂，SNRI）在神经病理性疼痛（特别是HIV相关性周围神经病变）管理中的作用机制的理解。\n\n解决此题的方法包括确定度洛西汀的药物类别（SNRI），并回忆其主要作用机制，即通过增强去甲肾上腺素信号传导来调节下行疼痛通路。这与其他镇痛药的机制形成对比。"
  },
  "tags": "Neuropathic pain; HIV-associated peripheral neuropathy; Duloxetine; SNRI; Serotonin-norepinephrine reuptake inhibitor; Descending pain modulation; Norepinephrine; Central nervous system; Pharmacology",
  "category": "Neuro",
  "question_id": "19482",
  "has_exhibits": false,
  "exhibit_count": 0,
  "exhibit_files": [],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Neuro 24\\19482",
  "extracted_at": "2025-11-05T19:37:50.013879",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 2,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T18:37:17.797185",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}